BioSpace News Archive

Ultragenyx Pharmaceutical, Inc. (Nasdaq: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases and Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT), a leading messenger RNA medicines company, today announced that Ultragenyx has exercised its option to purchase 600,000 shares of Arcturus common stock at $16.00 per share. “We are enco

Single doses of 0.5 mg KBP-5074 were generally well tolerated in patients with severe CKD, with or without hemodialysis Overall drug exposure was significantly lower in hemodialyzed patients vs. non-hemodialyzed patients Drug concentration is not altered during or after hemodialysis Plasma aldosterone and serum potassium were generally comparable between the two patient groups Preprint published online on MedRxiv PRINCETON, N.J., May 21, 2020 (GLOBE NEWSWIRE) -- KBP Bioscience

- Urovant Announces Publication of Phase 3 EMPOWUR Trial Results in the Journal of Urology - Urovant Announces U.S. FDA Acceptance of NDA for Vibegron in OAB - Myovant Submits Marketing Authorization Application to the European Medicines Agency for Relugolix Combination Therapy in Women with Uterine Fibroids - Altavant Sciences Acquires Onspira Therapeutics Adding Research Program to Potentially Address a Leading Cause of Death for Post-Lung Transplant Patients

Well-established dental health company, Oral Science will be attending ECRM’s Healthy Living/Vitamin and Nutrition Program for May. The Efficient Collaborative Retail Marketing (ECRM) Conference is a large-scale networking event designed to match established and up-and-coming brands with future retailers

Scientists from OpenCell.bio and King’s College London, in partnership with Opentrons Labworks, have developed a low-cost rapidly deployable COVID testing lab inside a shipping container that can process 2,400 tests per day. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200521005069/en/ This is the first fully functional lab that can be immediately deployed any

Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will participate in Craig-Hallum’s 17 th Annual Institutional Investor Conference on Wednesday, May 27, 2020, beginning at 10:00 a.m. ET. Each year, Craig-Hallum hosts a multi-industry investo

The Soileau Family-SPIE Optics and Photonics Undergraduate Scholarship Fund is part of a $2.5 million SPIE education funding initiative for optics and photonics BELLINGHAM, Wash.--( BUSINESS WIRE )-- On 21 May, SPIE, the international society for optics and photonics , announced the establishment of the Soileau Family-SPIE Optics and Photonics Undergraduate Scholarship Fund for the University of Central Florida’s (UCF) College of Optics and Photonics

Geron Corporation reported that it has granted a non-statutory stock option to purchase an aggregate of 70,000 shares of Geron common stock as an inducement to a newly-hired employee in connection with commencement of employment with the Company.

Sherlock Innovation Lab to Stimulate New England Economy by Creating New Jobs for Industry and Academic Experts Impacted by COVID-19 Pandemic Funding to Accelerate Development of INSPECTR™ Rapid Diagnostic Platform to Improve Testing in At-home and Low-resource Settings CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today an

AgeX Therapeutics , Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that Andrea Park has been appointed Chief Financial Officer. Ms. Park replaces Russell Skibsted who served in that role since the Company was organized in 2017. Andrea Park served as our Vice